Hepatitis B Virus-Associated Hepatocellular Carcinoma by Giacomo Emanuele Maria Rizzo, Giuseppe Cabibbo, Antonio Craxì

Get full text

NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis. by Anna Licata, Salvatore Corrao, Salvatore Petta, Chiara Genco, Mauro Cardillo, Vincenza Calvaruso, Giuseppe Cabibbo, Giuseppe Cabibbo, Fatima Massenti, Calogero Cammà, Giuseppe Licata, Antonio Craxì

Get full text

Hepatocellular carcinoma with macrovascular invasion: multimodality imaging features for the diagnosis by Roberto Cannella, Adele Taibbi, Giorgia Porrello, Marco Dioguardi Burgio, Giuseppe Cabibbo, Tommaso Vincenzo Bartolotta

Get full text

Survival of patients with hepatocellular carcinoma (HCC) treated by percutaneous radio-frequency ablation (RFA) is affected by complete radiological response. by Giuseppe Cabibbo, Giuseppe Cabibbo, Marcello Maida, Chiara Genco, Nicola Alessi, Marco Peralta, Giuseppe Butera, Massimo Galia, Giuseppe Brancatelli, Claudio Genova, Maurizio Raineri, Emanuele Orlando, Simona Attardo, Antonino Giarratano, Massimo Midiri, Vito Di Marco, Antonio Craxì, Calogero Cammà

Get full text

Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence by Ciro Celsa, Caterina Stornello, Paolo Giuffrida, Carmelo Marco Giacchetto, Mauro Grova, Gabriele Rancatore, Concetta Pitrone, Vito Di Marco, Calogero Cammà, Giuseppe Cabibbo

Get full text

Role of LI-RADS Indeterminate Observations in the Risk of Hepatocellular Carcinoma after HCV Eradication with Direct-Acting Antivirals by Federica Vernuccio, Roberto Cannella, Giuseppe Cabibbo, Silvia Greco, Ciro Celsa, Francesco Matteini, Paolo Giuffrida, Massimo Midiri, Vito Di Marco, Calogero Cammà, Giuseppe Brancatelli

Get full text

Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life Setting by Maria Corina Plaz Torres, Quirino Lai, Fabio Piscaglia, Eugenio Caturelli, Giuseppe Cabibbo, Elisabetta Biasini, Filippo Pelizzaro, Fabio Marra, Franco Trevisani, Edoardo G. Giannini

Get full text

Optimizing Sequential Systemic Therapies for Advanced Hepatocellular Carcinoma: A Decision Analysis by Giuseppe Cabibbo, Ciro Celsa, Marco Enea, Salvatore Battaglia, Giacomo Emanuele Maria Rizzo, Stefania Grimaudo, Domenica Matranga, Massimo Attanasio, Paolo Bruzzi, Antonio Craxì, Calogero Cammà

Get full text

Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma by Giuseppe Cabibbo, Ciro Celsa, Marco Enea, Salvatore Battaglia, Giacomo Emanuele Maria Rizzo, Anita Busacca, Domenica Matranga, Massimo Attanasio, Maria Reig, Antonio Craxì, Calogero Cammà

Get full text

Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma? by Massimo Galia, Adele Taibbi, Daniele Marin, Alessandro Furlan, Marco Dioguardi Burgio, Francesco Agnello, Giuseppe Cabibbo, Bernard E. Van Beers, Tommaso Vincenzo Bartolotta, Massimo Midiri, Roberto Lagalla, Giuseppe Brancatelli

Get full text

First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials by Giuseppe Cabibbo, Maria Reig, Ciro Celsa, Ferran Torres, Salvatore Battaglia, Marco Enea, Giacomo Emanuele Maria Rizzo, Salvatore Petta, Vincenza Calvaruso, Vito Di Marco, Antonio Craxì, Amit G. Singal, Jordi Bruix, Calogero Cammà

Get full text

Balancing Efficacy and Tolerability of First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis by Ciro Celsa, Giuseppe Cabibbo, David James Pinato, Gabriele Di Maria, Marco Enea, Marco Vaccaro, Salvatore Battaglia, Giacomo Emanuele Maria Rizzo, Paolo Giuffrida, Carmelo Marco Giacchetto, Gabriele Rancatore, Maria Vittoria Grassini, Calogero Cammà

Get full text

Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma by Maria Guarino, Valentina Cossiga, Mario Capasso, Chiara Mazzarelli, Filippo Pelizzaro, Rodolfo Sacco, Francesco Paolo Russo, Alessandro Vitale, Franco Trevisani, Giuseppe Cabibbo, on behalf of the Associazione Italiana per lo Studio del Fegato (AISF) HCC Special Interest Group

Get full text

Heart rate variability is associated with disease severity and portal hypertension in cirrhosis by Giuseppe Miceli, Vincenza Calvaruso, Alessandra Casuccio, Grazia Pennisi, Massimo Licata, Chiara Pintus, Maria G. Basso, Mariachiara Velardo, Mario Daidone, Emanuele Amodio, Salvatore Petta, Fabio Simone, Giuseppe Cabibbo, Domenico Di Raimondo, Antonio Craxì, Antonio Pinto, Antonino Tuttolomondo

Get full text

The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy: Strengths and Weaknesses of Surrogate Endpoints by Paolo Giuffrida, Ciro Celsa, Michela Antonucci, Marta Peri, Maria Vittoria Grassini, Gabriele Rancatore, Carmelo Marco Giacchetto, Roberto Cannella, Lorena Incorvaia, Lidia Rita Corsini, Piera Morana, Claudia La Mantia, Giuseppe Badalamenti, Giuseppe Brancatelli, Calogero Cammà, Giuseppe Cabibbo

Get full text

Inflammation and autonomic balance in cirrhosis: Association between sympathetic nervous system and osteopontin, interleukin‐22, interleukin‐6 and interleukin‐1Ra concentrations ac... by Giuseppe Miceli, Grazia Pennisi, Luisa Agnello, Vincenza Calvaruso, Emanuele Amodio, Alessandra Casuccio, Chiara Pintus, Maria Grazia Basso, Rosaria Maria Pipitone, Mario Daidone, Rossella Zito, Giulia Lupo, Salvatore Petta, Giuseppe Cabibbo, Marcello Ciaccio, Stefania Grimaudo, Antonio CraxÌ, Antonino Tuttolomondo

Get full text

Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications by Alessandro Vitale, Fabio Farinati, Michele Finotti, Chiara Di Renzo, Giuseppina Brancaccio, Fabio Piscaglia, Giuseppe Cabibbo, Eugenio Caturelli, Gabriele Missale, Fabio Marra, Rodolfo Sacco, Edoardo G. Giannini, Franco Trevisani, Umberto Cillo, Associazione Italiana per lo Studio del Fegato (AISF) HCC Special Interest Group, Italian Liver Cancer (ITA.LI.CA) Study Group

Get full text

The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib. by Francesco Caputo, Vincenzo Dadduzio, Francesco Tovoli, Giulia Bertolini, Giuseppe Cabibbo, Krisida Cerma, Caterina Vivaldi, Luca Faloppi, Mario Domenico Rizzato, Fabio Piscaglia, Ciro Celsa, Lorenzo Fornaro, Giorgia Marisi, Fabio Conti, Nicola Silvestris, Marianna Silletta, Sara Lonardi, Alessandro Granito, Caterina Stornello, Valentina Massa, Giorgio Astara, Sabina Delcuratolo, Stefano Cascinu, Mario Scartozzi, Andrea Casadei-Gardini

Get full text

Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma by Francesco Tovoli, Vincenzo Dadduzio, Stefania De Lorenzo, Lorenza Rimassa, Gianluca Masi, Massimo Iavarone, Fabio Marra, Ingrid Garajova, Maria Pia Brizzi, Bruno Daniele, Franco Trevisani, Carlo Messina, Francesco Di Clemente, Sara Pini, Giuseppe Cabibbo, Alessandro Granito, Mario Domenico Rizzato, Vittorina Zagonel, Giovanni Brandi, Tiziana Pressiani, Piera Federico, Caterina Vivaldi, Irene Bergna, Claudia Campani, Fabio Piscaglia

Get full text

REal life study of LEnVAtiNib therapy for HepAtocellular carcinoma: RELEVANT study by Andrea Casadei-Gardini, Margherita Rimini, Masatoshi Kudo, Shigeo Shimose, Toshifumi Tada, Goki Suda, Myung Ji Goh, Andre Jefremow, Mario Scartozzi, Giuseppe Cabibbo, Claudia Campani, Emiliano Tamburini, Francesco Tovoli, Kazuomi Ueshima, Tomoko Aoki, Hideki Iwamoto, Takuji Torimura, Takashi Kumada, Atsushi Hiraoka, Masanori Atsukawa, Ei Itobayashi, Hidenori Toyoda, Naoya Sakamoto, Takuya Sho, Wonseok Kang, Jürgen Siebler, Markus Friedrich Neurath, Valentina Burgio, Stefano Cascinu

Get full text